NIH Covid-19 treatment guidelines warn against drug combo pushed by Trump
4 years, 8 months ago

NIH Covid-19 treatment guidelines warn against drug combo pushed by Trump

CNN  

CNN — Doctors should not use a drug combination strongly pushed by President Donald Trump to treat patients with coronavirus infections, a National Institutes of Health panel says in new guidelines published Tuesday. “There are insufficient clinical data to recommend either for or against using the investigational antiviral drug remdesivir for the treatment of COVID-19,” the group adds. “There are insufficient clinical data to recommend either for or against the use of convalescent plasma or hyperimmune immunoglobulin for the treatment of COVID-19,” it said. Despite a few reports about patients who get a treatment that uses a pump to circulate their blood through an artificial exterior lung, called extracorporeal membrane oxygenation or ECMO, there’s not enough evidence to recommend it, the group said And health workers should be careful to wear the correct protective gear, such as fit-tested N95 respirator masks, when performing certain procedures that can shoot tiny particles of virus-carrying material, known as aerosols, into the air.

Treatment Drugs Trump Patients Cnn Panel Known Clinical Nih Drug Combo Insufficient Clinical Data  drug  combo  warn  drugs  panel  clinical  treatment  trump  guidelines  covid19  known  heart  nih  hydroxychloroquine  pushed  patients

History of this topic

Posts mislead on Mayo Clinic’s hydroxychloroquine webpage
55 years ago

Posts mislead on Mayo Clinic’s hydroxychloroquine webpage

Associated Press  

CLAIM: The Mayo Clinic “quietly” updated its website in 2023 to say that hydroxychloroquine can now be used to treat COVID-19. A page about hydroxychloroquine on the hospital system’s website included outdated guidance that the malaria drug “may also be used to treat coronavirus in certain hospitalized patients.” But archives show the text has been there since at least May …

WHO recommends Pfizer's pill Paxlovid for mild Covid cases
2 years, 8 months ago

WHO recommends Pfizer's pill Paxlovid for mild Covid cases

India Today  

The World Health Organisation has strongly recommended nirmatrelvir and ritonavir, sold under the name Paxlovid, for mild and moderate Covid-19 patients at highest risk of hospital admission. Pfizer’s oral antiviral drug is strongly recommended for patients with non-severe Covid-19 who are at highest risk of developing severe disease and hospitalisation, such as unvaccinated, older, or immunosuppressed patients. The global health …

Health Matters: Dear Drug Regulator, Silence is Not Always Golden, Esp on WHO Pausing Covaxin Supply
2 years, 8 months ago

Health Matters: Dear Drug Regulator, Silence is Not Always Golden, Esp on WHO Pausing Covaxin Supply

News 18  

On April 2, the World Health Organization suspended the supply of Bharat Biotech’s Covaxin through the UN agencies after finding issues with the “good manufacturing practices”. For the past 15 days, not only health journalists, but even commoners who got Covaxin jabs are hoping to hear from the country’s drug regulatory agency – Central Drugs Standard Control Organization. Eventually, the …

Have Covid-19 And In Home Isolation? Govt Advises On Medicines To Be Taken
2 years, 11 months ago

Have Covid-19 And In Home Isolation? Govt Advises On Medicines To Be Taken

ABP News  

New Delhi: The government expressed concern over "misuse and overuse" of Covid-19 drugs as cases continue to spike in India driven by the highly transmissible Omicron variant. Addressing a press conference, NITI Aayog Member Dr VK Paul said Covid-19 patients in home isolation should take paracetamol for fever and for cough, Ayush syrup could be used. Dr VK Paul said …

A shot in the arm: The Hindu Editorial on new modes of COVID-19 treatment
3 years ago

A shot in the arm: The Hindu Editorial on new modes of COVID-19 treatment

The Hindu  

If full vaccination using any COVID-19 vaccine greatly reduces a person’s risk of progressing to severe disease and death, then the move by the U.S. FDA to grant emergency-use authorisation to two oral antiviral drugs for certain categories of people who are likely to become severely ill provides a much-needed fillip to fight the disease. Unlike in the case of …

What you should know about treating Covid-19
3 years, 1 month ago

What you should know about treating Covid-19

Live Mint  

Within a few weeks, the US could have access to the first antiviral pills to treat Covid-19, either from Pfizer Inc. or Merck & Co. and partner Ridgeback Biotherapeutics LP. Doctors say an initial step is to monitor symptoms to determine whether infected people could be considered at low or high risk for developing severe disease. Patients who don’t respond …

Merck Covid pill: What would an antiviral pill mean for the fight against Covid-19?
3 years, 3 months ago

Merck Covid pill: What would an antiviral pill mean for the fight against Covid-19?

CNN  

CNN — Merck and Ridgeback Biotherapeutics announced on Friday early result that indicate their experimental oral antiviral drug molnupiravir might halve the risk of death or hospitalization from Covid-19. But Merck says it will seek authorization from the US Food and Drug Administration, and if it’s granted, the drug could be the first antiviral treatment available orally to fight Covid-19. …

WHO trial to study potential of 3 anti-malarial drugs against Covid
3 years, 4 months ago

WHO trial to study potential of 3 anti-malarial drugs against Covid

India TV News  

The World Health Organisation has announced a clinical trial to study three antimalarial and anti-inflammatory drugs as potential treatments for patients with Covid. The drugs -- artesunate, imatinib, and infliximab -- were selected by an independent expert panel for their potential in reducing the risk of death in hospitalized Covid-19 patients, the WHO said in a statement. "Finding more effective …

Remdesivir, HCQ have no antiviral effects: WHO study
3 years, 5 months ago

Remdesivir, HCQ have no antiviral effects: WHO study

India TV News  

Neither Remdesivir, nor hydroxychloroquine helps in recovery of patients hospitalised due to Covid-19, according to a new study conducted by the World Health Organization. The study, led by researchers from the Oslo University Hospital in Norway, found that lack of antiviral effect with Remdesivir and HCQ remained consistent despite patient age, symptom duration, degree of viral load, and presence of …

Anti-malarial drug shows promise in treating Covid-19
3 years, 6 months ago

Anti-malarial drug shows promise in treating Covid-19

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy As governments around the world race to vaccinate their populations, scientists …

Explained | Why has the Centre revised the protocol for mild COVID-19 cases, and which drugs are not recommended anymore?
3 years, 6 months ago

Explained | Why has the Centre revised the protocol for mild COVID-19 cases, and which drugs are not recommended anymore?

The Hindu  

The story so far: The Union Health Ministry has revised its guidelines for the treatment of COVID-19 patients, particularly for the use of steroids, with doctors reporting a worrying rise in medical complications, such as mucormycosis, due to the abuse of drugs and therapies during treatment. The revised guidelines, issued on May 27, recommend the use of antipyretics for fever …

Don't Use Remdesivir, Limit CT Scan, Steroid: Centre's Covid Treatment Guidelines for Kids
3 years, 7 months ago

Don't Use Remdesivir, Limit CT Scan, Steroid: Centre's Covid Treatment Guidelines for Kids

News 18  

The Centre late on Wednesday night released a list of guidelines to manage Covid-19 among children as anxiety over the third wave continues. AIIMS director Dr Randeep Guleria said that 60-70 percent of the children, who got infected and were hospitalised during the second wave, had either co-morbidities or low immunity, and healthy children recovered with mild illness without need …

Remember Donald Trump-touted hydroxychloroquine? Study in India backs it as Covid-19 cure
3 years, 7 months ago

Remember Donald Trump-touted hydroxychloroquine? Study in India backs it as Covid-19 cure

India Today  

Hydroxychloroquine, the malaria drug touted as a magical Covid-19 cure by former US President Donald Trump last year, has been found effective in a prophylactic study published in the Journal of The Association of Physicians of India last week. The study said, “hen adjusted for other risk factors, HCQ dose as per government recommendations, 2-3, 4-5, 6 or more weeks …

'Not a Life-Saving Drug': ICMR Suggests Safe Use of Remdesivir in Covid-19
3 years, 8 months ago

'Not a Life-Saving Drug': ICMR Suggests Safe Use of Remdesivir in Covid-19

News 18  

The Indian Council of Medical Research on Tuesday shared some suggestions for rational and safe use of Remdesivir in Covid-19 as the demand for the medicine has increased for treating coronavirus patients especially in Covid-hit states including Maharashtra, Delhi, Karnataka and others. Remdesivir is one of the investigational drugs approved for emergency use in treating hospitalized Covid-19 patients. Suggestion for …

Remdesivir Not Magic Bullet, Does Not Reduce Covid-19 Mortality: AIIMS Chief Randeep Guleria
3 years, 8 months ago

Remdesivir Not Magic Bullet, Does Not Reduce Covid-19 Mortality: AIIMS Chief Randeep Guleria

News 18  

Amid a steep spike in COVID-19 cases leading to increased demand for medicines for treating coronavirus, top health experts in the government on Monday said anti-viral drug remdesivir is "not a magic bullet" and does not reduce mortality. Addressing the media, AIIMS Director Dr Randeep Guleria said remdesivir should only be given to patients hospitalised with moderate illness, who had …

Lessons from COVID-19
3 years, 8 months ago

Lessons from COVID-19

The Hindu  

The SARS-CoV-2 pandemic was declared by the World Health Organization on March 11, 2020. It is important that lack of benefit of these drugs reported in well-conducted clinical trials should be translated into clinical practice by healthcare professionals managing COVID-19 patients. More recently, we have emerging evidence that two interleukin-6 receptor blocking drugs benefit COVID-19 patients, including enhanced benefit when …

Do not use 'miracle cure' ivermectin on COVID-19 patients says WHO
3 years, 9 months ago

Do not use 'miracle cure' ivermectin on COVID-19 patients says WHO

Firstpost  

The World Health Organization said Wednesday that ivermectin — touted by some on social media as a Covid-19 “miracle cure” — should not be used to treat coronavirus patients. The WHO said: “We recommend not to use ivermectin in patients with Covid-19 except in the context of a clinical trial.” Facebook posts and articles endorsing ivermectin have proliferated in Brazil, …

Hydroxychloroquine shouldn’t be used as Covid preventive, says WHO
3 years, 10 months ago

Hydroxychloroquine shouldn’t be used as Covid preventive, says WHO

Hindustan Times  

Anti-inflammatory drug hydroxychloroquine should not be used in efforts to prevent infection with Covid-19, according to the World Health Organization. Hydroxychloroquine was touted as a Covid-19 treatment by former President Donald Trump and later deemed ineffective. The WHO’s recommendation is based on evidence from six randomized controlled trials with more than 6,000 participants with or without known exposure to a …

Hydroxychloriquine critics are guilty of ‘medical McCarthyism’, controversial doctor says
4 years, 1 month ago

Hydroxychloriquine critics are guilty of ‘medical McCarthyism’, controversial doctor says

The Independent  

Sign up for the daily Inside Washington email for exclusive US coverage and analysis sent to your inbox Get our free Inside Washington email Get our free Inside Washington email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Critics of treatment drugs cleared for other diseases being used …

Coronavirus pandemic: WHO advises doctors not to use Gilead’s Remdesivir for Covid-19 treatment
4 years, 1 month ago

Coronavirus pandemic: WHO advises doctors not to use Gilead’s Remdesivir for Covid-19 treatment

Hindustan Times  

The World Health Organization recommended against using Gilead Sciences Inc.’s remdesivir to treat hospitalized Covid-19 patients less than a month after U.S. regulators granted the drug a speedy approval. “But personally, our view in our industry is to use the better controlled studies to evaluate the benefits of medicines.” ‘Relatively High Cost’ The FDA originally granted emergency use authorization to …

WHO advises against use of Remdesivir to treat COVID-19, says drug has no 'important effect' to reduce deaths
4 years, 1 month ago

WHO advises against use of Remdesivir to treat COVID-19, says drug has no 'important effect' to reduce deaths

Firstpost  

A WHO Guideline Development Group of international experts said there was ’no evidence based on currently available data that the anti-viral drug does improve patient-important outcomes' Paris: The anti-viral drug remdesivir should not be used to treat COVID-19 patients no matter how severe their illness as it has “no important effect” on survival chances, the World Health Organization said Friday. …

Steroid Treatment Should Be Reserved for Sickest Covid-19 Patients, Say Scientists
4 years, 1 month ago

Steroid Treatment Should Be Reserved for Sickest Covid-19 Patients, Say Scientists

News 18  

Most adults with moderate-to-severe COVID-19 have a suppressed immune response against the novel coronavirus rather than life-threatening hyper-inflammation, according to a study which suggests steroids such as dexamethasone should be reserved for the sickest patients. According to the research, published in the journal Science Advances, fewer than 5 per cent of the COVID-19 patients, including some of the sickest individuals, …

Remdesivir useless in covid fight: WHO
4 years, 2 months ago

Remdesivir useless in covid fight: WHO

Live Mint  

A World Health Organization trial of Gilead Sciences Inc.’s remdesivir, the antiviral drug used to treat US President Donald Trump, showed little or no effect on the survival rates of covid patients, a result that is in variance with the trial reports of the drugmaker. The WHO trial, which also studied the effect of hydroxychloroquine, a combination of HIV drugs …

WHO trial results show remdesivir has little or no effect for covid-19 patients
4 years, 2 months ago

WHO trial results show remdesivir has little or no effect for covid-19 patients

Live Mint  

Interim results from the World Health Organization’s solidarity trial showed that Gilead Sciences Inc’s remdesivir showed little or no effect for covid-19 patients, a result which was significantly different from the positive results shown by Gilead’s own trial. “These remdesivir, hydroxychloroquine, lopinavir and interferon regimens appeared to have little or no effect on hospitalized covid-19 patients, as indicated by overall …

WHO: Study finds four drugs that have little to no effect on coronavirus, including remdesivir
4 years, 2 months ago

WHO: Study finds four drugs that have little to no effect on coronavirus, including remdesivir

India Today  

The World Health Organisation announced Friday the long-awaited results of its six-month “Solidarity Therapeutics Trial” that endeavored to see if existing drugs might have an effect on the coronavirus. What the study found The study, which was not peer-reviewed, found that four treatments tested - remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon - had “ little or no effect" on whether or …

WHO trial finds remdesivir has little effect on COVID-19
4 years, 2 months ago

WHO trial finds remdesivir has little effect on COVID-19

Al Jazeera  

Early results from large, randomised trial suggest antiviral does little to reduce mortality rates or time in hospital. A World Health Organization trial using four drugs including the antiviral remdesivir in the hospital treatment of COVID-19 has found the repurposed medicines have little to no effect on the length of time patients spend in hospital or their survival. “These Remdesivir, …

Study advances use of indomethacin for treatment of mild cases
4 years, 2 months ago

Study advances use of indomethacin for treatment of mild cases

The Hindu  

A small study from India, but buttressed with a prospective larger study, soon to be published has advanced the case for the use of indomethacin, a powerful anti-inflammatory drug, in low doses, for effective treatment of milder COVID-19 cases. The results were very encouraging, and that became the basis for a project supported by IIT-Madras, studying the impact of indomethacin …

Hydroxycloroquine does not help with Covid mortality; Improves ICU risk
4 years, 2 months ago

Hydroxycloroquine does not help with Covid mortality; Improves ICU risk

NL Times  

Hydroxychloroquine, a malaria drug often used to treat Covid-19, does not have a noticeable effect on the mortality rate of the coronavirus, according to a study by 14 Dutch hospitals. The hospitals analyzed 1,064 Covid-19 patients in 14 hospitals, 189 of whom were treated with hydroxychloroquine, 377 were treated with chloroquine, and 498 were not treated with either of the …

(Explained) Trump’s Covid-19 treatments: Remdesivir, dexamethasone, antibody therapy, and more
4 years, 3 months ago

(Explained) Trump’s Covid-19 treatments: Remdesivir, dexamethasone, antibody therapy, and more

CNN  

CNN — President Trump’s physicians are giving him several different treatments – including investigational drugs – in the hope of relieving his Covid-19 symptoms and possibly shorten his course of illness. Dexamethasone President Trump was given the corticosteroid drug dexamethasone on Saturday after his oxygen level transiently dipped, White House physician Dr. Sean Conley said during a briefing on Sunday. …

Drug cocktail touted by Trump to treat coronavirus increases chance of death by 27%, study shows
4 years, 4 months ago

Drug cocktail touted by Trump to treat coronavirus increases chance of death by 27%, study shows

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy A combination of drugs touted by US president Donald Trump as …

FDA approves expanded emergency use of remdesivir in moderate COVID-19 patients
4 years, 4 months ago

FDA approves expanded emergency use of remdesivir in moderate COVID-19 patients

The Hindu  

Gilead Inc said on Friday the U.S. Food and Drug Administration expanded the emergency use authorization of its experimental antiviral COVID-19 treatment, remdesivir, to allow its use in all hospitalized COVID-19 patients. The drug was authorized in May for use in patients with a severe form of the illness, after trial data showed the antiviral drug helped shorten hospital recovery …

Amsterdam study shows hydroxychloroquine ineffective in Covid-19 treatment
4 years, 4 months ago

Amsterdam study shows hydroxychloroquine ineffective in Covid-19 treatment

NL Times  

Hydroxychloroquine was not effective in treating Covid-19 in Dutch hospitals during the coronavirus crisis, according to a study by Amsterdam scientists led by internist-infectiologist Edgar Peters of Amsterdam UMC. The Amsterdam researchers compared seven hospitals where Hydroxychloroquine was included in the treatment guideline in the early months of the crisis, to two hospitals where the drug was not prescribed. In …

Everything you wanted to know about covid-19 treatments, in five charts
4 years, 5 months ago

Everything you wanted to know about covid-19 treatments, in five charts

Live Mint  

When India’s National Task Force on COVID-19 recommended against including Itolizumab, Biocon’s psoriasis drug, in its treatment guidelines, the move represented two key aspects of the global scramble for a cure for covid-19 - the problematic bar for evidence, as well as the sheer size of the challenge. Perhaps no drug candidate in the race for a cure for covid-19 …

Where are we in finding a treatment for COVID-19?
4 years, 5 months ago

Where are we in finding a treatment for COVID-19?

Al Jazeera  

Some drugs and treatments have shown promise in clinical trials, while others are drawing controversy. More information on the efficacy of remdesivir in patients with COVID-19 is expected from large clinical trials such as the WHO-coordinated Solidarity Trial and the Recovery Trial in the United Kingdom. “It’s really important that these drugs be evaluated in robust clinical trials before being …

Hydroxychloroquine is a poor coronavirus treatment but a perfect parable for our times
4 years, 5 months ago

Hydroxychloroquine is a poor coronavirus treatment but a perfect parable for our times

ABC  

The group had all the trappings of medical authority. Since March 1, public posts containing the word "hydroxychloroquine" have received at least 55 million "interactions" on Facebook — a measure that includes reactions, shares or comments. And in the months since, President Trump and members of his administration have repeatedly returned to the hydroxychloroquine narrative despite the protests of White …

Trump Defends Use of Hydroxychloroquine, Says It Works in Early Stages of Covid-19 Infection
4 years, 5 months ago

Trump Defends Use of Hydroxychloroquine, Says It Works in Early Stages of Covid-19 Infection

News 18  

US President Donald Trump has again defended the use of hydroxychloroquine to ward off coronavirus, saying many frontline medical workers agree with him that the malaria drug works in the early stages of COVID-19 infection, despite mounting evidence that it is ineffective in treating the disease. I think frontline medical people believe that too — some, many," Trump told reporters …

Video falsely touts hydroxychloroquine as COVID-19 cure
4 years, 5 months ago

Video falsely touts hydroxychloroquine as COVID-19 cure

Associated Press  

CLAIM: A video makes numerous claims about preventing the coronavirus, stating that hydroxychloroquine can prevent and cure COVID-19, and wearing masks and keeping people locked down have no value. “There is no evidence done in a rigorous study that shows hydroxychloroquine in combination with azithromycin or zinc or whatever combination you use that has any benefit in the treatment of …

Trump again pushes unproven hydroxychloroquine as Covid-19 treatment
4 years, 5 months ago

Trump again pushes unproven hydroxychloroquine as Covid-19 treatment

Live Mint  

WASHINGTON: A week after appearing to project a more serious tone about the coronavirus, President Donald Trump is back to pushing unproven claims that an anti-malaria drug is an effective treatment and challenging the credibility of the nation's leading infectious disease expert. The president also shared a post from the Twitter account for a podcast hosted by Steve Bannon, a …

Scientists identify 21 existing drugs that block coronavirus in lab studies
4 years, 5 months ago

Scientists identify 21 existing drugs that block coronavirus in lab studies

Live Mint  

Scientists, including those of Indian-origin, have identified 21 existing drugs that stop the replication of the novel coronavirus which causes COVID-19 in lab studies, an advance that may lead to the development of new therapeutic combinations against the disease. Of the 21 drugs that were effective at blocking viral replication, the scientists found that 13 have previously entered clinical trials …

New studies clarify what drugs help, hurt for COVID-19
4 years, 5 months ago

New studies clarify what drugs help, hurt for COVID-19

Associated Press  

Fresh studies give more information about what treatments do or don’t work for COVID-19, with high-quality methods that give reliable results. It reduced deaths by 36% for patients sick enough to need breathing machines: 29% on the drug died versus 41% given usual care. After 28 days, about 25.7% on hydroxychloroquine had died versus 23.5% given usual care -- a …

Hydroxychloroquine doesn’t work in non-hospitalized patients
4 years, 5 months ago

Hydroxychloroquine doesn’t work in non-hospitalized patients

CNN  

CNN — The antimalarial drug hydroxychloroquine did not benefit non-hospitalized patients with mild Covid-19 symptoms who were treated early in their infection, according to a study published Thursday in the medical journal Annals of Internal Medicine. “Taken together, there is no convincing evidence that hydroxychloroquine can either prevent COVID-19 after exposure or reduce illness severity after developing early symptoms,” study …

No room for complacency, says PM Modi after COVID-19 review
4 years, 5 months ago

No room for complacency, says PM Modi after COVID-19 review

The Hindu  

Prime Minister Narendra Modi on Saturday, following a COVID-19 review meeting with Home Minister Amit Shah, Health Minister Harsh Vardhan and other senior government officials, reiterated the need to observe personal hygiene and social discipline in public places while appreciating the manner in which the pandemic has been “contained” in Delhi. “There are 2,83,407 active cases and all are under …

Gilead says remdesivir reduced risk of death in coronavirus patients, more studies needed
4 years, 6 months ago

Gilead says remdesivir reduced risk of death in coronavirus patients, more studies needed

India Today  

Gilead Sciences Inc said on Friday additional data from a late-stage study showed its antiviral remdesivir reduced the risk of death and significantly improved the conditions of severely ill COVID-19 patients. Gilead said it analyzed data from 312 patients treated in a late-stage study and a separate real-world retrospective cohort of 818 patients with similar characteristics and disease severity as …

Coronavirus: Hydroxychloroquine trialled over better treatments
4 years, 6 months ago

Coronavirus: Hydroxychloroquine trialled over better treatments

Daily Mail  

More than 1,200 studies looking at treatment and prevention of coronavirus are often too small to provide conclusive results and are focusing too much on one potential therapy, a new analysis reveals. Commissioned by STAT News, the report found that one in every six clinical trials studied the anti-malaria drugs hydroxychloroquine or chloroquine despite thin evidence that either are effective …

US prescriptions for hydroxychloroquine skyrocketed from February to March, study finds
4 years, 6 months ago

US prescriptions for hydroxychloroquine skyrocketed from February to March, study finds

CNN  

CNN — Prescriptions for the anti-malarial drugs chloroquine and hydroxychloroquine skyrocketed in the US from February to March, a time when the drugs, though unproven, were touted as treatments for the coronavirus. Researchers found the estimated number of hydroxychloroquine prescriptions increased 86.2% from February to March, from 367,346 to 683,999, and dispensed chloroquine prescriptions increased 158.6%, rising from 2,346 to …

WHO ending hydroxychloroquine trial for COVID
4 years, 6 months ago

WHO ending hydroxychloroquine trial for COVID

LA Times  

The World Health Organization says it is ending a trial into whether the anti-malaria drug hydroxychloroquine helps patients hospitalized with COVID-19. The WHO said Saturday it has “accepted the recommendation” from the committee overseeing the trial to discontinue testing of hydroxychloroquine and lopinavir/ritonavir, a drug combination used to treat HIV/AIDS. The United Nations agency says a review of the interim …

COVID-19 treatment: Fabiflu by Glenmark, HCQ, Remdesivir and other drugs that are being used to treat coronavirus patients
4 years, 6 months ago

COVID-19 treatment: Fabiflu by Glenmark, HCQ, Remdesivir and other drugs that are being used to treat coronavirus patients

Firstpost  

Over nine million people globally have tested positive for COVID-19 so far, of which, 4,25,000 are in India. Glenmark Pharmaceuticals, a research-led pharmaceutical company, received the approval for manufacturing and marketing Favipiravir, an antiviral drug to be used for the treatment of mild to moderate COVID-19 patients, from the Drugs Controller General of India on Friday, 19 June 2020. Favipiravir: …

Hydroxychloroquine: NIH halts clinical trial after finding no additional benefit for Covid-19 patients
4 years, 6 months ago

Hydroxychloroquine: NIH halts clinical trial after finding no additional benefit for Covid-19 patients

CNN  

CNN — The National Institutes of Health announced Saturday that it has halted a clinical trial evaluating the safety and effectiveness of drug hydroxychloroquine as a treatment for adults hospitalized with Covid-19. “A data and safety monitoring board met late Friday and determined that while there was no harm, the study drug was very unlikely to be beneficial to hospitalized …

NIH Halts Hydroxychloroquine Study; Says 'Unlikely' To Help COVID-19 Patients
4 years, 6 months ago

NIH Halts Hydroxychloroquine Study; Says 'Unlikely' To Help COVID-19 Patients

NPR  

NIH Halts Hydroxychloroquine Study; Says 'Unlikely' To Help COVID-19 Patients Enlarge this image toggle caption Lev Radin/Pacific Press/Pacific Press/LightRocket via Ge Lev Radin/Pacific Press/Pacific Press/LightRocket via Ge The National Institutes of Health has halted its study of hydroxychloroquine, a drug President Donald Trump has promoted as a possible treatment for COVID-19 and once claimed to be taking himself. In a …

How dexamethasone might lead researchers to better COVID-19 treatments
4 years, 6 months ago

How dexamethasone might lead researchers to better COVID-19 treatments

LA Times  

The steroid drug dexamethasone can be lifesaving for patients with severe COVID-19. In preliminary clinical trial results announced Tuesday, patients on mechanical ventilators who were treated with the steroid dexamethasone were 35% less likely to die of COVID-19 than their counterparts who got standard care without the drug. A medication like dexamethasone is a “blunt instrument,” said Dr. Steven J. …

Discover Related